Home
About
Services
Partners
Client Portfolio
News
Contact
‘Lemon’ or not, Trump stuck with Phase 1 China trade deal for now
June 1, 2020
Coty names Chairman Harf as CEO to oversee turnaround
June 1, 2020
0
Eli Lilly starts human study of potential COVID-19 antibody treatment
Published by
Muller&Green
at
June 1, 2020
Categories
RSS
Tags
Eli Lilly and Co said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world’s first study of an antibody treatment against the disease.
Powered by
WPeMatico
Muller&Green
Related posts
December 17, 2024
Five Lessons From My Mentor
Read more
December 13, 2024
Where Does Corporate Climate Action Go Next?
Read more
December 12, 2024
CEO of the Year Lisa Su Talks Competition and Collaboration in the Semiconductor Industry
Read more